Traumatic hemoptysis treated with recombinant human factor VIIa.
Blunt thoracic trauma resulting in massive hemoptysis is rare. Although there are several indications for the administration of recombinant factor VIIa, we are unaware of a report of its utilization in the treatment of hemoptysis following chest trauma. We report a case of the successful use of factor VIIa in the treatment of life-threatening hemoptysis secondary to blunt force thoracic injury and traumatic coagulopathy.
O'Connor
James V
JV
Department of Thoracic and Vascular Surgery, R. Adams Cowley Shock Trauma Center, Baltimore, Maryland 21201, USA. joconnor@umm.edu
Stein
Deborah M
DM
Dutton
Richard P
RP
Scalea
Thomas M
TM
D000328:Adult; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006469:Hemoptysis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013898:Thoracic Injuries / Q000150:complications*; D014949:Wounds, Nonpenetrating / Q000150:complications*
D011994:Recombinant Proteins; D015942:Factor VIIa